Arianna Ferrari Christopher Coenen Armin Grunwald Arnold Sauter ...

Coenen C., Gammel S., Heil R., Woyke A. (Hg.) (2010): Die Debatte über
Human Enhancement. Historische, philosophische und ethische Aspekte der
technologischen Verbesserung des Menschen. Transcript Verlag: Bielefeld.
Coenen C., Schuijff M., Smits M., Klaasen P., Hennen L., Rader M., Wolbring
G. (2009): Human Enhancement (IPOL/A/STOA/2007-13; PE 417.483)
Europäisches Parlament: Brüssel, http://www.itas.fzk.de/eng/etag/document/2009/coua09a.pdf
(zuletzt aufgerufen am 23/07/10).
Coenen C., Hennen L., Link H.-J. (2009): The ethics of synthetic biology.
Contours of an emerging discourse, Technikfolgenabschätzung – Theorie und
Praxis 2, 18, S. 82–86.
Comstock G. (1992): What obligations have scientists to transgenic animals?
Discussion Paper CBPE 92-8 (College Station, Texas: Center for Biotechnology
Policy and Ethics, Texas A&M University, 1992).
Comstock G. (2000): Vexing Nature? On the ethical case against agricultural
biotechnology. Kluiver: Boston, Dordrecht, London.
Conn M.P. (ed.) (2006): Handbook of models for human Aging.
Springer: Amsterdam, Boston.
Cooper D. (1998): Intervention, Humility and Animal Integrity. In: Holland A,
Johnson A. (Hg.) Animal Biotechnology and Ethics.
Chapman and Hall: London: 145–155.
Cooper D.K. et al. (2007): [alpha]1,3-Galactosyltransferase Gene-Knockout
Pigs for Xenotransplantation: Where Do We Go From Here?,
Transplantation 84, 1: 1–7.
Council for Responsible Genetics (CRG) (1997): Aufruf: Für ein weltweites
Verbot der Klonierung von Menschen und für eine breite Debatte über die
Biotechnologie, Gen-ethisches Netzwerk 25.07.1997: 30.
Cowey A., Stoerig P. (1995): Blindsight in monkeys, Nature 373: 247–249.
Cozzi E., Bosio E., Seveso M. et al (2009): Xenotransplantation as a model
of integrated, multidisciplinary research, Organogenesis 5(1): 288–296.
Cozzi E., Tallacchini M., Flanagan E.B. et al. (2009): The International
Xenotransplantation Association consensus statement on conditions for under-
taking clinical trials of porcine islet products in type 1 diabetes – chapter 1:
Key ethical requirements and progress toward the definition of an international
regulatory framework, Xenotransplantation 16(4): 203–14.
Cozzi E. (2009): On the road to clinical xenotransplantation,
Transplation Immunology 21(2): 57–59.
Cromie W. (1999): Gene Boosts Muscle Strength: Mighty Mice Raise Hopes
For A Stronger Life, Harvard Gazette 11 February 1999, http://www.news.har-
vard.edu/gazette/1999/02.11/muscle.html (zuletzt aufgerufen am 23/07/10).
Crook A. (2001): Cosmetic Surgery in North America and Latin America,
Protocols of the World Small Anima Veterinary Association: 54–55.
Cross N., Phillips C.J. (2009): Requirements for the welfare of baboons and
pigs used in animal-to-animal xenotransplantation experiments,
Australian veterinary journal 87(10):421–6.
Cui Z., Lindl K.A., Mei B. et al. (2005): Requirement of NMDA receptor reac-
tivation for consolidation and storage of nondeclarative taste memory revealed
by inducible NR1 knockout, European Journal of Neuroscience 22(3): 755–763.
Cundiff L.V., Bishop M.D., Johnson R.K. (1993): Challenges and opportunities
for integrating genetically modified animals into traditional animal breeding
plans, Journal Animal Science 71 Suppl 3:20–5.
Cunliffe J. (2003): Hunde – Rassen, Pflege, Geschichte. Parragon Books: Prag.
Daniels N. (2000): Normal Functioning and Treatment – Enhancement
Distinction, Cambridge Quarterly of Healthcare Ethics 9: 309–322.
Danish Council of Bioethics (2008): Man or Mouse? Ethical Aspects of
Chimaera Research, The Danish Council of Bioethics http://www.etiskraad.dk/
sw16983.asp (zuletzt aufgerufen 16/08/10).
Darian-Smith C. (2007): Monkey Models of Recovery of Voluntary Hand Movement
after Spinal Cord and Dorsal Root Injury, ILAR Journal 48(4): 396–410.
178 Animal Enhancement | Beiträge zur Ethik und Biotechnologie Animal Enhancement | Beiträge zur Ethik und Biotechnologie
179